125 related articles for article (PubMed ID: 9743289)
1. Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells.
Kondoh N; Yamada T; Kihara-Negishi F; Yamamoto M; Oikawa T
Br J Cancer; 1998 Sep; 78(6):718-23. PubMed ID: 9743289
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
3. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
Kitange G; Shibata S; Tokunaga Y; Yagi N; Yasunaga A; Kishikawa M; Naito S
Lab Invest; 1999 Apr; 79(4):407-16. PubMed ID: 10211993
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines.
Shiratsuchi T; Ishibashi H; Shirasuna K
J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986
[TBL] [Abstract][Full Text] [Related]
6. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.
Medcalf RL; Richards RI; Crawford RJ; Hamilton JA
EMBO J; 1986 Sep; 5(9):2217-22. PubMed ID: 3780677
[TBL] [Abstract][Full Text] [Related]
7. Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin.
Wilcox SA; Reho T; Higgins PJ; Tominna-Sebald E; McKeown-Longo PJ
Biochem Cell Biol; 1996; 74(6):899-910. PubMed ID: 9164658
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
9. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
Biliran H; Sheng S
Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
[TBL] [Abstract][Full Text] [Related]
10. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
[TBL] [Abstract][Full Text] [Related]
11. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors.
Nakada M; Yamashita J; Okada Y; Sato H
J Neuropathol Exp Neurol; 1999 Apr; 58(4):329-34. PubMed ID: 10218628
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.
Laug WE; Cao XR; Yu YB; Shimada H; Kruithof EK
Cancer Res; 1993 Dec; 53(24):6051-7. PubMed ID: 8261421
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
16. Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular α-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogen.
Kim YT; Kim SK; Jeon YJ; Park SJ
BMB Rep; 2014 Dec; 47(12):691-6. PubMed ID: 24602611
[TBL] [Abstract][Full Text] [Related]
17. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
Pakneshan P; Szyf M; Rabbani SA
Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
19. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.
Guo Y; Xie J; Rubin E; Tang YX; Lin F; Zi X; Hoang BH
Cancer Res; 2008 May; 68(9):3350-60. PubMed ID: 18451162
[TBL] [Abstract][Full Text] [Related]
20. Activation of anchorage-independent growth of HT1080 human fibrosarcoma cells by dexamethasone.
Kondoh N; Shuda M; Arai M; Oikawa T; Yamamoto M
In Vitro Cell Dev Biol Anim; 2002 Feb; 38(2):111-7. PubMed ID: 11928993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
